Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Tomas Krivulcik"'
Autor:
Bozena Smolkova, Michal Mego, Viera Horvathova Kajabova, Zuzana Cierna, Ludovit Danihel, Tatiana Sedlackova, Gabriel Minarik, Iveta Zmetakova, Tomas Krivulcik, Paulina Gronesova, Marian Karaba, Juraj Benca, Daniel Pindak, Jozef Mardiak, James M. Reuben, Ivana Fridrichova
Publikováno v:
Translational Oncology, Vol 9, Iss 3, Pp 184-190 (2016)
Circulating tumor cells (CTCs) are independent prognostic factors in the primary and metastatic breast cancer patients and play crucial role in hematogenous tumor dissemination. The aim of this study was to correlate the presence of CTCs in periphera
Externí odkaz:
https://doaj.org/article/259ced29cec34d88a2bc929ebadc5405
Autor:
Tomas Krivulcik, Bozena Smolkova, Miroslav Chovanec, Michal Mego, Marian Karaba, Tatiana Sedlackova, Juraj Benca, Ludovit Danihel, Gabriel Minarik, Viera Horvathova Kajabova, Zuzana Sestakova, Dana Jurkovicova, Ivana Fridrichova, Lenka Kalinkova, Zuzana Cierna, Monika Magyerkova, Ludovit Kulcsar, Iveta Zmetakova
Publikováno v:
Oncotarget
// Dana Jurkovicova 1, 2 , Bozena Smolkova 2 , Monika Magyerkova 1 , Zuzana Sestakova 2 , Viera Horvathova Kajabova 2 , Ludovit Kulcsar 1 , Iveta Zmetakova 2 , Lenka Kalinkova 2 , Tomas Krivulcik 2 , Marian Karaba 3 , Juraj Benca 3, 4 , Tatiana Sedla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1bbfc2a9232a302473b2b935629ec70
http://europepmc.org/articles/PMC5652785
http://europepmc.org/articles/PMC5652785
Autor:
Naouale El Yamani, Lucia Kucerova, Viera Horvathova Kajabova, Svetlana Miklikova, Tomas Krivulcik, Iveta Zmetakova, Miroslava Matuskova, Bozena Smolkova, Zduriencikova M, Lenka Kalinkova, Maria Dusinska, Ivana Fridrichova, Andrea Babelova
Publikováno v:
Neoplasma (Bratislava)
Epithelial-to-mesenchymal transition (EMT) significantly affects the risk of metastasising in breast cancer. Plasticity and reversibility of EMT suggest that epigenetic mechanisms could be the key drivers of these processes, but little is known about
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2768657daf0da4c4238a5d69b4313466
http://hdl.handle.net/11250/2592199
http://hdl.handle.net/11250/2592199
Autor:
M Tomka, Tomas Krivulcik, Vladimir Bella, Zora Lasabova, Viera Horvathova Kajabova, Ivana Fridrichova, Katarina Sebova, Iveta Zmetakova, S Galbavy, Karol Kajo, Iveta Stankovicova
Publikováno v:
Cancer Biomarkers. 10:13-26
Breast cancer is the most common cancer in women worldwide, representing 28.2% of all female malignancies. In addition to genetic changes, epigenetic events, as aberrant DNA methylation and histone modification, are responsible for cancer development
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::871137a0996a2792f3f0f679858dc687
https://doi.org/10.3233/cbm-2012-0230
https://doi.org/10.3233/cbm-2012-0230
Publikováno v:
Neoplasma. 56:101-107
UNLABELLED The human multidrug resistance gene (MDR1) is encoding the transmembrane transporter P-glycoprotein (P-gp) which plays an important role in the efflux of various drugs and thus is potentially influencing the drug-treatment outcome. It has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f88b8884901d05599f9e26ef35b754c
https://doi.org/10.4149/neo_2009_02_101
https://doi.org/10.4149/neo_2009_02_101
Autor:
Michal Mego, Tomas Krivulcik, Ivana Fridrichova, Martin Bohac, Viera Horvathova Kajabova, Juraj Benca, Iveta Zmetakova, Bozena Smolkova, Marian Karaba, Zuzana Cierna, Vanda Repiská, Daniel Pindak, Ludovit Danihel
Publikováno v:
Translational research : the journal of laboratory and clinical medicine. 165(6)
More than 25% of the patients with breast cancer (BC) develop metastatic disease. In the present study, we investigated the relationship between DNA methylation levels in genes regulating cell growth, invasiveness, and metastasis and advanced BCs and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b03d8e7900bdfac067db824ba4d5bcd
https://pubmed.ncbi.nlm.nih.gov/25620615
https://pubmed.ncbi.nlm.nih.gov/25620615
Autor:
I Rusnak, P Blasko, Michal Mego, Tomas Krivulcik, Ludovit Danihel, Vanda Repiská, Bozena Smolkova, Iveta Zmetakova, Marian Karaba, D Danis, Ivana Fridrichova, B Rychly, Juraj Benca, Viera Horvathova Kajabova, Juraj Pechan
Publikováno v:
Neoplasma. 60(6)
Breast carcinoma is the most common cancer with high mortality caused by metastatic disease. New molecular biomarkers predicting the tumour's metastatic potential would therefore improve metastasis prevention and personalised care. The aim of the stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::708205c38f8135fdfe44f9d5531383fb
https://pubmed.ncbi.nlm.nih.gov/23906298
https://pubmed.ncbi.nlm.nih.gov/23906298
Autor:
Tomas Slamka, Zdena Bartosova, Bujalkova M, Tomas Krivulcik, David Martinicky, Denisa Ilencikova, Katarina Zavodna
Publikováno v:
BMC Cancer, Vol 9, Iss 1, p 405 (2009)
BMC Cancer
BMC Cancer
Background Depending on the population studied, large genomic rearrangements (LGRs) of the mismatch repair (MMR) genes constitute various proportions of the germline mutations that predispose to hereditary non-polyposis colorectal cancer (HNPCC). It
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2afc68d21bf2c5543c5db12149655318
https://doi.org/10.1186/1471-2407-9-405
https://doi.org/10.1186/1471-2407-9-405
Autor:
R Behulova, Katarina Zavodna, S Spanik, J Kausitz, S Galbavy, E Weismanova, Tomas Krivulcik, M Vizvaryova, M Konecny
Publikováno v:
Neoplasma. 56(3)
Colorectal carcinoma (CRC) represents a serious problem worldwide: in the Slovak republic are diagnosed about 2600 new CRC cases annually and its incidence is increasing. Colorectal cancer patients may succumb to the disease because of local recurren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb2adeed0cf17fd82a5a5380b4f553a3
https://pubmed.ncbi.nlm.nih.gov/19309232
https://pubmed.ncbi.nlm.nih.gov/19309232
Autor:
Katarina Zavodna, Michal Konecny, Juraj Kausitz, Frantisek Cisarik, Miriam Vizvaryova, Bujalkova M, Behulova R, Eva Weismanova, Tomas Krivulcik
Publikováno v:
Breast cancer research and treatment. 119(1)
Mutations in the BRCA1 and BRCA2 genes account for the majority of hereditary breast ovarian cancer (HBOC) cases. However, after BRCA1 and BRCA2 screening still the most HBOC cases remain negative for any mutational event. Accordingly, in these cases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3be28ea5ce69c0538b9be25c4c8f7b3c
https://pubmed.ncbi.nlm.nih.gov/19011960
https://pubmed.ncbi.nlm.nih.gov/19011960